"At Vero Beach Neurology and Research Institute we are more than a doctor’s office, we are a group of caregivers that maintain, as our utmost priority, to provide personalized, compassionate and comprehensive evidence based neurological care and research. From our front desk staff, nurses, technologists, research team and clinical providers, we all take to heart your care and comfort during and throughout your patient experience. We treat, not only you as the patient, but your whole family as caregivers, spouses and family members also experience the life changing events associated with acute and chronic neurological illness. We are more than just a doctor’s office we are a family that treats you like family."

During the past decade, Vero Beach Neurology and Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vero Beach Neurology and Research Institute" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Novartis" with 3 trials sponsored, "Actelion" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vero Beach Neurology and Research Institute" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vero Beach Neurology and Research Institute" are "Multiple Sclerosis" (8 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Alzheimers Disease" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "NMO Spectrum Disorder (NMOSD)" (1 trials). Many other conditions were trialed in "Vero Beach Neurology and Research Institute" in a lesser frequency.

Most popular intervention types in "Vero Beach Neurology and Research Institute" are "Drug" (14 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ocrelizumab" (5 trials), "ASA 100 mg" (1 trials), "Avonex" (1 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vero Beach Neurology and Research Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Vero Beach Neurology and Research Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Vero Beach Neurology and Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Vero Beach Neurology and Research Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".